Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA CAPITAL MANAGEMENT L.P. | 5,516,067 9.800% | 645,000 (+13.24%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | ImmunoGen, Inc. IMGN | RA CAPITAL MANAGEMENT L.P. | 22,075,158 9.990% | -87,800 (-0.40%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | 5:01 Acquisition Corp. FVAM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,431,901 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Synlogic, Inc. SYBX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -444,444 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Adicet Bio, Inc. ACET | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -147,772 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,588,081 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Entera Bio Ltd. ENTX | RA CAPITAL MANAGEMENT L.P. | 295,966 1.000% | -2,057,034 (-87.42%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | IO Biotech, Inc. IOBT | RA CAPITAL MANAGEMENT L.P. | 1,127,260 3.900% | -730,495 (-39.32%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Instil Bio, Inc. TIL | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -383,540 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 7,691,990 9.990% | -41,086,182 (-84.23%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA CAPITAL MANAGEMENT L.P. | 7,040,622 9.600% | 2,075,034 (+41.79%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA CAPITAL MANAGEMENT L.P. | 3,984,681 6.200% | -1,629,747 (-29.03%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Bitwise MARA Option Income Strategy ETF IMRA | RA CAPITAL MANAGEMENT L.P. | 812,681 12.400% | 7,475 (+0.93%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RA CAPITAL MANAGEMENT L.P. | 6,428,483 9.990% | 2,876,975 (+81.01%) | Filing History |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Geron Corporation GERN | RA CAPITAL MANAGEMENT L.P. | 48,423,211 9.990% | 16,034,412 (+49.51%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,246,503 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,282,173 (Position Closed) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,850,000 (Position Closed) | Filing History |